115 related articles for article (PubMed ID: 36823700)
1. Offering on-site mammography in workplaces improved screening rates: Cluster randomized controlled trial.
Shima A; Tanaka H; Okamura T; Nishikawa T; Morino A; Godai K; Tatsumi Y; Kawahara M; Kiyohara M; Kawatsu Y; Kimura T; Miyamatsu N
J Occup Health; 2023 Jan; 65(1):e12389. PubMed ID: 36823700
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study.
Lång K; Josefsson V; Larsson AM; Larsson S; Högberg C; Sartor H; Hofvind S; Andersson I; Rosso A
Lancet Oncol; 2023 Aug; 24(8):936-944. PubMed ID: 37541274
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Adjunctive Ultrasonography for Breast Cancer Detection Among Women Aged 40-49 Years With Varying Breast Density Undergoing Screening Mammography: A Secondary Analysis of a Randomized Clinical Trial.
Harada-Shoji N; Suzuki A; Ishida T; Zheng YF; Narikawa-Shiono Y; Sato-Tadano A; Ohta R; Ohuchi N
JAMA Netw Open; 2021 Aug; 4(8):e2121505. PubMed ID: 34406400
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial to verify the efficacy of the use of ultrasonography in breast cancer screening aged 40-49 (J-START): 76 196 women registered.
Ishida T; Suzuki A; Kawai M; Narikawa Y; Saito H; Yamamoto S; Tohno E; Sobue T; Fukuda M; Ohuchi N
Jpn J Clin Oncol; 2014 Feb; 44(2):134-40. PubMed ID: 24407835
[TBL] [Abstract][Full Text] [Related]
6. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
Colditz GA
Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
[TBL] [Abstract][Full Text] [Related]
7. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
[TBL] [Abstract][Full Text] [Related]
8. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
[TBL] [Abstract][Full Text] [Related]
9. Workplace-based breast cancer screening intervention in china.
Ma GX; Yin L; Gao W; Tan Y; Liu R; Fang C; Ma XS
Cancer Epidemiol Biomarkers Prev; 2012 Feb; 21(2):358-67. PubMed ID: 22155948
[TBL] [Abstract][Full Text] [Related]
10. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
11. Effect of an information leaflet on breast cancer screening participation: A cluster randomized controlled trial.
Montero-Moraga JM; Posso M; Román M; Burón A; Sala M; Castells X; Macià F
BMC Public Health; 2021 Jul; 21(1):1301. PubMed ID: 34217258
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial.
Ohuchi N; Suzuki A; Sobue T; Kawai M; Yamamoto S; Zheng YF; Shiono YN; Saito H; Kuriyama S; Tohno E; Endo T; Fukao A; Tsuji I; Yamaguchi T; Ohashi Y; Fukuda M; Ishida T;
Lancet; 2016 Jan; 387(10016):341-348. PubMed ID: 26547101
[TBL] [Abstract][Full Text] [Related]
13. Effect of Patient Navigation on Breast Cancer Screening Among African American Medicare Beneficiaries: A Randomized Controlled Trial.
Marshall JK; Mbah OM; Ford JG; Phelan-Emrick D; Ahmed S; Bone L; Wenzel J; Shapiro GR; Howerton M; Johnson L; Brown Q; Ewing A; Pollack CE
J Gen Intern Med; 2016 Jan; 31(1):68-76. PubMed ID: 26259762
[TBL] [Abstract][Full Text] [Related]
14. The effect of information about the benefits and harms of mammography on women's decision-making: study protocol for a randomized controlled trial.
Carles M; Martínez-Alonso M; Pons A; Pérez-Lacasta MJ; Perestelo-Pérez L; Sala M; Vidal C; Garcia M; Toledo-Chávarri A; Codern N; Feijoo-Cid M; Romero A; Pla R; Soler-González J; Castells X; Rué M;
Trials; 2017 Sep; 18(1):426. PubMed ID: 28899412
[TBL] [Abstract][Full Text] [Related]
15. Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial.
Houssami N; Bernardi D; Caumo F; Brunelli S; Fantò C; Valentini M; Romanucci G; Gentilini MA; Zorzi M; Macaskill P
Breast; 2018 Apr; 38():150-153. PubMed ID: 29328943
[TBL] [Abstract][Full Text] [Related]
16. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial.
Moss SM; Wale C; Smith R; Evans A; Cuckle H; Duffy SW
Lancet Oncol; 2015 Sep; 16(9):1123-1132. PubMed ID: 26206144
[TBL] [Abstract][Full Text] [Related]
17. [Natural history of breast cancer: a systematic review of worldwide randomized controlled trials of mammography screening].
Yue XP; Shi JF; Mao AY; Wang L; Ma HM; Chen LL; Zhu J; Cheng X; Dai M
Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):154-160. PubMed ID: 28219215
[No Abstract] [Full Text] [Related]
18. What do European women know about their female cancer risks and cancer screening? A cross-sectional online intervention survey in five European countries.
Wegwarth O; Widschwendter M; Cibula D; Sundström K; Portuesi R; Lein I; Rebitschek FG;
BMJ Open; 2018 Dec; 8(12):e023789. PubMed ID: 30593552
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of a tailored intervention designed to increase breast cancer screening among a non-adherent population: a randomized controlled trial.
Ishikawa Y; Hirai K; Saito H; Fukuyoshi J; Yonekura A; Harada K; Seki A; Shibuya D; Nakamura Y
BMC Public Health; 2012 Sep; 12():760. PubMed ID: 22962858
[TBL] [Abstract][Full Text] [Related]
20. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
